Kidney-Sparing combo therapy aims to beat cancer without losing the organ
NCT ID NCT07504939
First seen Apr 08, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study tests a treatment plan for a rare cancer of the kidney and ureter that avoids removing the whole kidney. Patients first have a less invasive surgery to remove the tumor, then receive targeted drugs and radiation. The goal is to see if this approach can prevent the cancer from coming back while keeping the kidney working. The trial involves 36 adults with high-risk disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER TRACT UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Departmeng of Urology, Peking University First Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.